Page last updated: 2024-08-26

fulvestrant and Menopause

fulvestrant has been researched along with Menopause in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sharma, R; Zhang, ZJ; Zheng, Y; Zhou, XD	1
Conte, P; Frassoldati, A; Guarneri, V	1
Emons, G; Friess, SC; Frosch, KH; Gründker, C; Hofbauer, LC; Nisslein, T; Raddatz, D; Schoppet, M; Viereck, V	1
Anderson, E; Blamey, RW; Bundred, NJ; DeFriend, DJ; Dowsett, M; Howell, A; Mansel, RE; Nicholson, RI; Robertson, JF; Saunders, C	1
Honjo, H; Hosoda, T; Nakajima, H	1
Baum, M	1

Reviews

1 review(s) available for fulvestrant and Menopause

Article	Year
A vision for the future? British journal of cancer, 2001, Volume: 85 Suppl 2 Topics: Anastrozole; Breast Neoplasms; Estradiol; Female; Fulvestrant; Goserelin; Humans; Menopause; Nitriles; Tamoxifen; Triazoles	2001

Trials

1 trial(s) available for fulvestrant and Menopause

Article	Year
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer research, 1994, Jan-15, Volume: 54, Issue:2 Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Ki-67 Antigen; Menopause; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Receptors, Estrogen; Receptors, Progesterone	1994

Other Studies

4 other study(ies) available for fulvestrant and Menopause

Article	Year
Total Polysaccharides of Lily Bulb Ameliorate Menopause-Like Behavior in Ovariectomized Mice: Multiple Mechanisms Distinct from Estrogen Therapy. Oxidative medicine and cellular longevity, 2019, Volume: 2019 Topics: Animals; Anxiety; Behavior, Animal; Brain; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Lilium; Menopause; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Ovariectomy; Oxidative Stress; Plant Roots; Polysaccharides; Signal Transduction; Uterus	2019
The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients. Cancer biology & therapy, 2009, Volume: 8, Issue:15 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cholesterol; Clinical Trials as Topic; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Inflammation; Lipid Metabolism; Liver; Menopause; Neoplasms, Hormone-Dependent; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators	2009
Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:11 Topics: 2-Propanol; Adult; Alkaline Phosphatase; Carrier Proteins; Cell Differentiation; Cells, Cultured; Cimicifuga; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression; Glycoproteins; Humans; Male; Membrane Glycoproteins; Menopause; Osteoblasts; Osteocalcin; Osteoporosis, Postmenopausal; Osteoprotegerin; Plant Extracts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Progesterone; Receptors, Tumor Necrosis Factor; RNA, Messenger	2005
Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death. Neuroreport, 2001, Jul-03, Volume: 12, Issue:9 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Calcium; Cell Survival; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Replacement Therapy; Fulvestrant; Intracellular Fluid; Menopause; Mitochondria; Nerve Degeneration; Neurons; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Rats; Tamoxifen	2001